These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20043114)

  • 21. S100P, a potential novel prognostic marker in colorectal cancer.
    Wang Q; Zhang YN; Lin GL; Qiu HZ; Wu B; Wu HY; Zhao Y; Chen YJ; Lu CM
    Oncol Rep; 2012 Jul; 28(1):303-10. PubMed ID: 22552710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural maintenance of chromosomes 4 is a predictor of survival and a novel therapeutic target in colorectal cancer.
    Feng XD; Song Q; Li CW; Chen J; Tang HM; Peng ZH; Wang XC
    Asian Pac J Cancer Prev; 2014; 15(21):9459-65. PubMed ID: 25422241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma.
    Sun XF; Rütten S; Zhang H; Nordenskjöld B
    J Clin Oncol; 1999 Jun; 17(6):1745-50. PubMed ID: 10561211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma.
    Li Q; Li Y; Xu J; Wang S; Xu Y; Li X; Cai S
    Cell Physiol Biochem; 2017; 42(1):397-406. PubMed ID: 28558381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
    Ballesté B; Bessa X; Piñol V; Castellví-Bel S; Castells A; Alenda C; Paya A; Jover R; Xicola RM; Pons E; Llor X; Cordero C; Fernandez-Bañares F; de Castro L; Reñé JM; Andreu M;
    Dis Colon Rectum; 2007 Jul; 50(7):971-80. PubMed ID: 17468913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonality and heterogeneity of metachronous colorectal cancer.
    Di J; Yang H; Wang Z; Yang J; Gao P; Jiang B; Su X
    Mol Carcinog; 2019 Mar; 58(3):447-457. PubMed ID: 30499617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.
    Jiang Z; Xu Y; Cai S
    Hum Pathol; 2011 Mar; 42(3):361-8. PubMed ID: 21111449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of transarterial chemoembolization combined with systemic chemotherapy for patients with KRAS wild-type unresectable metachronous colorectal carcinoma with liver metastases.
    Yu Q; Zhang L; Fan S; Huang L; Wang X; Xindun C
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C205-C211. PubMed ID: 28230018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.
    Hao H; Xia G; Wang C; Zhong F; Liu L; Zhang D
    Med Mol Morphol; 2017 Jun; 50(2):76-85. PubMed ID: 27981410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.